Vanaja Krishnan joins George Clinical, India as its Managing Director

New Delhi, September 28, 2016: George Clinical welcomes Vanaja Krishnan as the new Managing Director of George Clinical, India. Vanaja has a Master’s degree in Commerce and professional qualifications in both Cost & Financial management and corporate compliance. She has 25 years’ experience in global organizations such as Molex Inc. & Sigma Aldrich (now a subsidiary of Merck) as CFO and other Senior Leadership roles in Finance, Human Resources, Information Systems and Sourcing & Procurement. More recently, Vanaja was responsible for establishing and leading Global Shared Services for Sigma Aldrich.

“We welcome Vanaja to the George Clinical team at a very exciting time in our organizations history,” Dr Marisa Petersen, Executive Director of George Clinical said. “We have been conducting both global and local clinical trials in India since 2008 and are continuing to grow strongly again since the downturn of 2013 – 2015. India is of critical importance to our full-trial service offering throughout Asia. As such, we require a highly motivated and experienced executive to lead our operational activities in the country and we feel confident we have found this in Vanaja. We see her decision to join us as an endorsement of our organization’s reputation in the sector and the region.”

Vanaja has expressed her enthusiasm for joining an organization that holds scientific excellence at the heart of what they do. “George Clinical appeals to me as it aligns to my values,” Vanaja said.“I strive to contribute and stay connected to the objective of improving the quality of life around us. I believe that George Clinical, through itsemphasis on quality science, is an organisation that aims to make a positive difference in the world.”

For more information about how George Clinical, India can make a difference to your clinical trial, please contact us on info@georgeclinical.com or visit our website at www.georgeclinical.com

George Clinical

George Clinical is a leading independent clinical research organisation (CRO) in Asia with over 200 staff operating in 11 countries. George Clinical provides a full range of clinical trial services to pharmaceutical, medical device and biotech customers, for all trial phases, registration and post-marketing trials. George Clinical combines scientific and clinical leadership with expert trial delivery capability,in order to deliver a distinctive world-class service. George Clinical’s parent organization, The George Institute for Global Health, is a leader in chronic disease research, with a global network of experts with whom George Clinical engages. George Clinical delivers an operationally supported, internationally recognized scientific leadership service, bringing together an extensive series of investigator networks that allow George Clinical to provide customizable clinical trial excellence from trial design through all aspects of delivery.

For more details contact George Clinical on info@georgeclinical.com

Corporate Comm India(CCI Newswire)